Clinical Trials Sponsored by CerSci Therapeutics

Total 6294 results

Lotus Clinical Research, LLC
CerSci Therapeutics

Unknown

Double-blind, Placebo-control, Study to Evaluate the Safety and Pharmacokinetics of CT-044 HCl, in Healthy Volunteers

Surgery | Pain, Acute | Acute Pain | Neuropathy

United States
Lotus Clinical Research, LLC
CerSci Therapeutics

Completed

Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers

Surgery | Pain, Acute | Acute Pain | Neuropathy

United States
Cesca Therapeutics, Inc.

Unknown

Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System (CLIRST III)

Critical Limb Ischemia (CLI)
Cerecin

Completed

Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production

Alzheimer Disease

United States
Cerecin

Completed

Taste-masking Study for Tricaprilin in Sensory Panelists (TMS)

Taste Profile Assessments

United States
Cerecin

Completed

Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production

Alzheimer Disease

Australia
Cerecin

Withdrawn

Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides

Alzheimer Disease
Cerecin

Withdrawn

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) (ALERT)

Alzheimer's Disease

United States
Cerecin

Completed

A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects

Alzheimer Disease

United States
Cerecin

Terminated

Tricaprilin Liquid Formulation PK Study

Alzheimer Disease

Australia
Cerecin

Withdrawn

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Alzheimer's Disease
Cerecin

Completed

Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly

Alzheimer's Disease

United States
Cerecin

Not yet recruiting

Tricaprilin Phase 3 AD Study

Alzheimer Disease
Cerecin

Completed

Tricaprilin Phase 2 Pilot Study in Migraine

Migraine

Australia
Cerecin

Completed

AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

Alzheimer Disease

Australia
Cerecin

Active, not recruiting

Tricaprilin Infantile Spasms Pilot Study

Infantile Spasm

Singapore, Australia
Cerecin

Completed

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext (NOURISH-AD)

Alzheimer's Disease

United States
Cerecin

Completed

Tricaprilin in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Cerecin

Completed

Tricaprilin In Age-Associated Memory Impairment

Age-Associated Memory Impairment

United States
Cerecin

Completed

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Alzheimer Disease

Australia
Cerecin

Completed

Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease (ACT)

Alzheimer's Disease
Cerecin
Celerion

Completed

Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production

Healthy

United States
Cerecin
Celerion

Completed

Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

Healthy

United States
Cerecin
Celerion

Completed

Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production

Healthy

United States
Verici Dx

Recruiting

Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection

Kidney Transplant Rejection

United States, United Kingdom, Italy, France, Spain
Cerecin
Celerion

Completed

Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production

Healthy

United States
Ceric Sàrl

Terminated

Physio PCI: Impact of Coronary Angioplasty on Non-hyperaemic Pressure Ratio in Patients With Coronary Artery Disease

Coronary Artery Disease

United Arab Emirates
Ceric Sàrl

Active, not recruiting

Keep bIfurcation Single Stenting Simple (KISS)

Coronary Disease

United Kingdom, France, Spain, Italy, Portugal, Switzerland
Fondazione Golgi Cenci

Completed

Remote Testing in Abbiategrasso (RTA) (RTA)

Cognitive Assessment

Italy
Ceric Sàrl
Abbott

Terminated

CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardiac Arrest Patients

Out of Hospital Cardiac Arrest

Belgium, France, Serbia
Ceric Sàrl
Electroducer

Not yet recruiting

Feasibility Study Evaluating the Safety and Efficacy of the Renal Stimulation by Direct Wire Pacing, During Renal Denervation Procedure (RNS by DWP)

Essential Hypertension
Ceric Sàrl
Symetis SA

Completed

Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation II (SCOPE II)

Aortic Valve Stenosis

Germany, France, Spain, United Kingdom, Denmark, Italy
Ranok Therapeutics (Hangzhou) Co., Ltd.

Recruiting

A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Advanced Solid Tumor | DLBCL

United States
Perrigo CSCI

Recruiting

Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation

Head Lice Infestation

Mauritius
Aysel Sesci

Recruiting

The Effect of Stress Ball Application Before Coronary Angiography on Stress, Anxiety and Vital Signs

Coronary Artery Disease

Turkey
Ospedale Santa Maria delle Croci

Completed

Efficacy of 2-Liter Mixed Preparation With Bisacodyl Plus Polyethylene Glycol and 4-Liter Polyethylene Glycol for Colon Cleansing in Patients With Prior History of Colorectal Resection (PEGOP)

Intestinal Cancer

Italy
Perrigo CSCI

Recruiting

Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation

Head Lice

Mauritius
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Type 2 Diabetes Mellitus With Diabetic Nephropathy

United States
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (CAPACITY-HFpEF)

Heart Failure With Preserved Ejection Fraction

United States, Canada
Ospedale Santa Maria delle Croci

Recruiting

Short-course Antimicrobial Therapy in Sepsis

Sepsis | Septic Shock | Severe Sepsis | Infection

Italy
Ceric Sàrl
Boston Scientific Corporation

Completed

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization. (SENIOR)

Acute Coronary Syndrome | Stable Angina | Silent Myocardial Ischemia

France, Spain, Belgium, Switzerland, United Kingdom, Latvia, Finland, Italy, North Macedonia
CRISPR Therapeutics AG

Recruiting

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Clear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal Carcinoma

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)

T Cell Lymphoma

United States, Australia, Canada
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)

B-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALL

United States, Spain, Canada, France, Germany, Australia
Bacainn Therapeutics, Inc.

Completed

A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects

Healthy Volunteers

United States
Celsus Therapeutics PLC

Terminated

Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% (C012013)

Atopic Dermatitis

Israel
Eikon Therapeutics
Impact Therapeutics, Inc.

Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

Advanced Solid Tumor

Australia, United States
APRINOIA Therapeutics, LLC

Active, not recruiting

A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants

Alzheimer Disease | Tauopathies | Healthy Volunteers

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Renal Cell Carcinoma

United States, Australia, Canada, Netherlands
Ceric Sàrl
European Cardiovascular Research Center

Not yet recruiting

The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis (BSC07)

Severe Aortic Valve Stenosis

Lebanon, Saudi Arabia, Egypt

3

Subscribe